FDA Combination Products Office Finalizing Manufacturing, Adverse Event Rules
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Office of Combination Products is also developing guidance on how to determine whether a medical product is a device, drug or biologic.